Loading...
Not a good buy right now. Despite a post-market bounce (+5.01%), the stock just suffered a large regular-session selloff (-9.86%), technical momentum is not strengthening (MACD positive but contracting), and the latest quarter fundamentals deteriorated sharply (2025/Q3 revenue -16.05% YoY, EPS -0.06). With no Intellectia buy signals today and pattern-based odds favoring further downside over the next week/month, an impatient buyer is better off staying on the sidelines rather than chasing the after-hours rebound.
Price/Trend: Big regular-session drop followed by a partial post-market rebound suggests unstable/whippy price action rather than a clean uptrend. Momentum: MACD histogram is above 0 (0.548) but positively contracting, indicating bullish momentum is fading rather than accelerating. RSI: RSI(6)=65.6 (neutral-to-near-overbought), not signaling a fresh oversold entry. Moving averages: Converging MAs typically indicate consolidation/indecision, not a strong trend. Levels: Pivot ~12.29 is the key near-term reference; resistance at R1 ~15.48 (then ~17.45). Support zone is much lower (S1 ~9.11). Quant/pattern bias: Similar-pattern stats imply a mild negative drift (-2.74% 1w, -5.41% 1m), which is unfavorable for an impatient entry.
Intellectia Proprietary Trading Signals

Post-market rebound (+5.01%) after a sharp regular-session drop could attract short-term mean-reversion traders.
MACD remains above zero, implying the broader momentum backdrop is not outright bearish yet.
Call open interest heavily outweighs put open interest (though liquidity is thin).
Major regular-session selloff (-9.86%) signals strong selling pressure.
MACD bullish momentum is contracting, not strengthening.
No news in the past week—no obvious catalyst to justify buying immediately.
Pattern-based outlook suggests further downside over the next week/month.
Options market is extremely thin (near-zero puts, minimal volume), reducing confidence in sentiment signals and increasing execution/slippage risk.
Latest quarter: 2025/Q3. Revenue: 92.68M, down -16.05% YoY (clear top-line contraction). Net income: -2.83M, down -91.10% YoY (profitability worsened materially). EPS: -0.06, down -91.18% YoY. Gross margin: 55.97, down -17.88% YoY. Overall: The quarter shows weakening growth and margins, which does not support an aggressive buy-now decision.
No analyst rating or price target change data was provided, so there is no visible recent Wall Street upgrade/downgrade trend to lean on. Pros/cons view from analysts cannot be reliably assessed from the current dataset. Influential/political trading: No recent congress trading data available; hedge funds and insiders are neutral with no significant recent trend.
